Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001753926-25-001175
Filing Date
2025-07-23
Accepted
2025-07-23 21:17:40
Documents
1
Period of Report
2025-07-02

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6703
  Complete submission text file 0001753926-25-001175.txt   8333
Mailing Address 1410 SMYTHE ST DANIEL ISLAND SC 29492
Business Address
Plesha Scott M. (Reporting) CIK: 0001726687 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41964 | Film No.: 251144327

Mailing Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703
Business Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703 919-908-2422
Pelthos Therapeutics Inc. (Issuer) CIK: 0001919246 (see all company filings)

EIN.: 863335449 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)